Who to follow: HealthTech executives
MM
Michael McCullar, PhD
Chief Executive Officer · RegCell
Pharma & Life SciencesNorth AmericaEstablished
Why follow Michael
Leading epigenetic Treg reprogramming, co-founded with Nobel laureate Shimon Sakaguchi, backed by a $44M Series A.
Writes about
Cell therapyAutoimmune diseaseTransplant tolerance
Best for
Researchers and investors following regulatory T-cell and autoimmune platforms